This chapter examines the interplay between tumor microenvironmental factors and metabolic reprogramming in cancer, framing a new paradigm for precision oncology. It details the cellular and noncellular components of the tumor microenvironment, emphasizing the roles of stromal and immune cells such as cancer-associated fibroblasts, endothelial cells, and tumor-associated macrophages, in driving tumor growth, metastasis, and therapy resistance. The discussion explores how metabolic adaptations, including the Warburg effect, and altered lipid and amino acid metabolism, promote proliferation under stress and facilitate immune evasion. The dynamic feedback loops between tumor cells and their microenvironment that foster angiogenesis and immunosuppression are highlighted, alongside emerging strategies to disrupt these interactions via metabolic inhibitors, dietary interventions, and nanotechnology-based drug delivery systems. By integrating high-throughput omics, spatial profiling, metabolic imaging, and molecular pathological epidemiology, this chapter provides a framework for refined patient stratification and the rational design of combination therapies tailored to individual tumor ecosystems.